SCHEMBL21499301

SCHEMBL21499301

CC(C)(C)c1ccc(C(=O)Nc2cc3c(cc2O)NCCCC3)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.57
ALDH1A1 P00352 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
MAPT P10636 2/20 0.57
LMNA P02545 1/20 0.57
HPGD P15428 1/20 0.57
HTT P42858 1/20 0.57
TRPV1 Q8NER1 1/20 0.47
NR1H4 Q96RI1 4/20 0.46
MAPK14 Q16539 2/20 0.45
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
NPC1 O15118 1/20 0.44
GLA P06280 1/20 0.44
RAB9A P51151 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
DHPS P49366 2/20 0.42
PLAU P00749 1/20 0.41
KIT P10721 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21499325 0.88 DHODH (0.56) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21468548 0.86 MAPT (0.76) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21499390 0.86 SMN1; SMN2 (0.54) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21499302 0.85 SMN1; SMN2 (0.53) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21468526 0.84 DHODH (0.71) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21499304 0.84 MAPT (0.60) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21499364 0.83 MAPT (0.59) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21499303 0.83 DHODH (0.59) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL21499352 0.81 PLAU (0.58) DHODHALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL23090384 0.81 DHODH (0.56) DHODHALDH1A1SMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450263-B2 Benzo annulenes as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2019-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450263-B2 Benzo annulenes as antiviral agents MAVS, ZC3HAV1, GABBR1 DHODH 593/4885ALDH1A1 187/4885SMN1; SMN2 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.